Literature DB >> 22791215

Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.

Soledad Betanzos-Lara1, Olga Novakova, Robert J Deeth, Ana M Pizarro, Guy J Clarkson, Barbora Liskova, Viktor Brabec, Peter J Sadler, Abraha Habtemariam.   

Abstract

The synthesis and characterization of complexes [(η(6)-arene)Ru(N,N')X][PF(6)], where arene is para-cymene (p-cym), biphenyl (bip), ethyl benzoate (etb), hexamethylbenzene (hmb), indane (ind) or 1,2,3,4-tetrahydronaphthalene (thn), N,N' is 2,2'-bipyrimidine (bpm) and X is Cl, Br or I, are reported, including the X-ray crystal structures of [(η(6)-p-cym)Ru(bpm)I][PF(6)], [(η(6)-bip)Ru(bpm)Cl][PF(6)], [(η(6)-bip)Ru(bpm)I][PF(6)] and [(η(6)-etb)Ru(bpm)Cl][PF(6)]. Complexes in which N,N' is 1,10-phenanthroline (phen), 1,10-phenanthroline-5,6-dione or 4,7-diphenyl-1,10-phenanthroline (bathophen) were studied for comparison. The Ru(II) arene complexes undergo ligand-exchange reactions in aqueous solution at 310 K; their half-lives for hydrolysis range from 14 to 715 min. Density functional theory calculations on [(η(6)-p-cym)Ru(bpm)Cl][PF(6)], [(η(6)-p-cym)Ru(bpm)Br][PF(6)], [(η(6)-p-cym)Ru(bpm)I][PF(6)], [(η(6)-bip)Ru(bpm)Cl][PF(6)], [(η(6)-bip)Ru(bpm)Br][PF(6)] and [(η(6)-bip)Ru(bpm)I][PF(6)] suggest that aquation occurs via an associative pathway and that the reaction is thermodynamically favourable when the leaving ligand is I > Br ≈ Cl. pK (a)* values for the aqua adducts of the complexes range from 6.9 to 7.32. A binding preference for 9-ethylguanine (9-EtG) compared with 9-ethyladenine (9-EtA) was observed for [(η(6)-p-cym)Ru(bpm)Cl][PF(6)], [(η(6)-hmb)Ru(bpm)Cl](+), [(η(6)-ind)Ru(bpm)Cl](+), [(η(6)-thn)Ru(bpm)Cl](+), [(η(6)-p-cym)Ru(phen)Cl](+) and [(η(6)-p-cym)Ru(bathophen)Cl](+) in aqueous solution at 310 K. The X-ray crystal structure of the guanine complex [(η(6)-p-cym)Ru(bpm)(9-EtG-N7)][PF(6)](2) shows multiple hydrogen bonding. Density functional theory calculations show that the 9-EtG adducts of all complexes are thermodynamically preferred compared with those of 9-EtA. However, the bmp complexes are inactive towards A2780 human ovarian cancer cells. Calf thymus DNA interactions for [(η(6)-p-cym)Ru(bpm)Cl][PF(6)] and [(η(6)-p-cym)Ru(phen)Cl][PF(6)] consist of weak coordinative, intercalative and monofunctional coordination. Binding to biomolecules such as glutathione may play a role in deactivating the bpm complexes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22791215     DOI: 10.1007/s00775-012-0917-9

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  42 in total

1.  Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex.

Authors:  Hong-Ke Liu; Susan J Berners-Price; Fuyi Wang; John A Parkinson; Jingjing Xu; Juraj Bella; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2006-12-11       Impact factor: 15.336

2.  Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.

Authors:  Nadine Summa; Wolfgang Schiessl; Ralph Puchta; Nico van Eikema Hommes; Rudi van Eldik
Journal:  Inorg Chem       Date:  2006-04-03       Impact factor: 5.165

Review 3.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

4.  Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.

Authors:  Anna F A Peacock; Abraha Habtemariam; Rafael Fernández; Victoria Walland; Francesca P A Fabbiani; Simon Parsons; Rhona E Aird; Duncan I Jodrell; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2006-02-08       Impact factor: 15.419

5.  DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.

Authors:  Olga Novakova; Haimei Chen; Oldrich Vrana; Alison Rodger; Peter J Sadler; Viktor Brabec
Journal:  Biochemistry       Date:  2003-10-07       Impact factor: 3.162

6.  Inhibition of cancer cell growth by ruthenium(II) arene complexes.

Authors:  R E Morris; R E Aird; P del S Murdoch; H Chen; J Cummings; N D Hughes; S Parsons; A Parkin; G Boyd; D I Jodrell; P J Sadler
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

7.  Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes.

Authors:  O Nováková; J Kaspárková; O Vrána; P M van Vliet; J Reedijk; V Brabec
Journal:  Biochemistry       Date:  1995-09-26       Impact factor: 3.162

8.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

9.  Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.

Authors:  Fuyi Wang; Haimei Chen; Simon Parsons; Iain D H Oswald; James E Davidson; Peter J Sadler
Journal:  Chemistry       Date:  2003-12-05       Impact factor: 5.236

10.  Conformational transitions of alternating purine-pyrimidine DNAs in perchlorate ethanol solutions.

Authors:  M Vorlícková
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

View more
  6 in total

1.  Binding and interaction of di- and tri-substituted organometallic triptycene palladium complexes with DNA.

Authors:  Rina Kumari; Sourav Bhowmick; Neeladri Das; Prolay Das
Journal:  J Biol Inorg Chem       Date:  2014-07-27       Impact factor: 3.358

2.  Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.

Authors:  Mickaël Marloye; Haider Inam; Connor J Moore; Vinciane Debaille; Justin R Pritchard; Michel Gelbcke; Franck Meyer; François Dufrasne; Gilles Berger
Journal:  J Biol Inorg Chem       Date:  2021-06-26       Impact factor: 3.358

3.  Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.

Authors:  Gan-Jian Lin; Guang-Bin Jiang; Yang-Yin Xie; Hong-Liang Huang; Zhen-Hua Liang; Yun-Jun Liu
Journal:  J Biol Inorg Chem       Date:  2013-08-30       Impact factor: 3.358

4.  Inhibition of cancer cell growth by ruthenium complexes.

Authors:  Joji Iida; Elisabeth T Bell-Loncella; Marc L Purazo; Yifeng Lu; Jesse Dorchak; Rebecca Clancy; Julianna Slavik; Mary Lou Cutler; Craig D Shriver
Journal:  J Transl Med       Date:  2016-02-12       Impact factor: 5.531

5.  Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.

Authors:  Pavel Štarha; Zdeněk Trávníček; Ján Vančo; Zdeněk Dvořák
Journal:  Molecules       Date:  2018-02-14       Impact factor: 4.411

6.  ATP7B Binds Ruthenium(II) p-Cymene Half-Sandwich Complexes: Role of Steric Hindrance and Ru-I Coordination in Rescuing the Sequestration.

Authors:  Kallol Purkait; Arindam Mukherjee; Arnab Gupta
Journal:  Inorg Chem       Date:  2019-10-28       Impact factor: 5.165

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.